Corcept Therapeutics Inc. buy Truist Financial Co.
Start price
06.11.23
/
50%
€24.00
Target price
06.11.24
€35.38
Performance (%)
-5.00%
Price
03.05.24
€22.80
Summary
This prediction is currently active. With a performance of -5.00%, the BUY prediction for Corcept Therapeutics Inc. by Truist_Financial_Co_ is down slightly. This prediction currently runs until 06.11.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Corcept Therapeutics Inc. | 6.942% | 6.942% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $38.00 price target on the stock, up previously from $29.00.
Ratings data for CORT provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Corcept Therapeutics Inc.
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.88
02.05.24
02.05.24
€41.15
02.05.25
02.05.25
-0.35%
03.05.24
03.05.24
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.60
16.02.24
16.02.24
€39.06
16.02.25
16.02.25
0.89%
03.05.24
03.05.24